News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NovaBay Pharmaceuticals, Inc. (NBY) Reports Fourth Quarter Financial Results and 2013 Clinical and Business Update


3/14/2013 11:15:22 AM

EMERYVILLE, Calif., March 14, 2013 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global topical, non-systemic anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today gave a fourth quarter financial and clinical update and outlook for 2013.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES